Novel Tyrosinase Inhibitors From Natural Resources - Their Computational Studies

被引:1
|
作者
Khan, M. T. H. [1 ]
机构
[1] Univ Illinois, Ctr Pharmaceut Biotechnol, Coll Pharm, Chicago, IL 60607 USA
关键词
Mushroom tyrosinase; tyrosinase inhibitors; molecular docking; QSAR; 3D-QSAR; CoMFA; CoMSIA; HUMAN EPIDERMAL MELANOCYTES; MELANIN BIOSYNTHESIS PATHWAY; COPPER ACTIVE-SITE; MUSHROOM TYROSINASE; POTENT TYROSINASE; IN-VITRO; DRUG DISCOVERY; PRENYLATED FLAVONOIDS; SOPHORA-FLAVESCENS; AGARICUS-BISPORUS;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tyrosinase is a multi-copper enzyme widely distributed in different organisms, including plants & mammals, etc., which is responsible for pigmentations, undesired browning of fruits and vegetables. This is the key enzyme in the melanogenesis in human and molting process of insects. Therefore the inhibitors of the enzyme may lead to novel skin whitening agents, anti-browning substances or compounds for insect control. A large numbers of moderate to potent tyrosinase inhibitors have been reported during the last decade. From our group, we reported a number of potent inhibitors from synthetic, semi-synthetic and natural origins. The compounds are from several chemical classes, like phenolics, terpenes, steroids, chalcones, flavonoids, alkaloids, long-chain fatty acids, coumarins, sildenafil analogs, bipiperidines, biscoumarins, oxadiazole, tetraketones, etc. More recently, the crystal structure of mushroom and couple of other tyrosinases has been published and more recently the crystal structure of mushroom tyrosinase complexes with a highly potent inhibitor tropolone has been reported. Yet there is a lack of information of inhibitor-tyrosinase intermolecular interactions. To overcome such issues, some researchers started utilizing in silico tools, like molecular docking simulations, for such purposes. There are also few papers published about the successful utilization of computational tools like QSAR-based and ligand-based virtual screening to identify novel and potent inhibitors of the enzyme. In our group, we are using all possible computational tools, like ligand-based as well structure-based approaches, to identify new inhibitors. In this review, some of such examples are briefly described.
引用
收藏
页码:2262 / 2272
页数:11
相关论文
共 50 条
  • [31] In silico and in vitro studies of novel derivatives of tyrosol and raspberry ketone as the mushroom tyrosinase inhibitors
    Mohammadsadeghi, Nahid
    Mahdavi, Atiyeh
    Saadati, Fariba
    Mohammadi, Fakhrossadat
    FOOD CHEMISTRY, 2023, 424
  • [32] Phosphonic and Phosphinic Acid Derivatives as Novel Tyrosinase Inhibitors: Kinetic Studies and Molecular Docking
    Wolinska, Ewa
    Haldys, Katarzyna
    Gora, Jerzy
    Olszewski, Tomasz K.
    Boduszek, Bogdan
    Latajka, Rafal
    CHEMISTRY & BIODIVERSITY, 2019, 16 (07)
  • [33] Molecular design of tyrosinase inhibitors: A critical review of promising novel inhibitors from synthetic origins
    Khan, Mahmud Tareq Hassan
    PURE AND APPLIED CHEMISTRY, 2007, 79 (12) : 2277 - 2295
  • [34] Natural and Synthetic Tyrosinase Inhibitors as Antibrowning Agents: An Update
    Loizzo, M. R.
    Tundis, R.
    Menichini, F.
    COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, 2012, 11 (04): : 378 - 398
  • [35] Computational study on novel natural inhibitors targeting c-MET
    Hou, Yuanyuan
    Xie, Haoqun
    Dou, Gaojing
    Yang, Wenzhuo
    Ge, Junliang
    Zhou, Baolin
    Ren, Junan
    Li, Juncheng
    Wang, Jing
    Zhang, Zhiyun
    Wang, Xinhui
    MEDICINE, 2021, 100 (38)
  • [36] Computational study on novel natural inhibitors targeting BCL2
    Lv, Xiaye
    Jiang, Yuting
    Wang, Xinhui
    Xie, HaoQun
    Dou, Gaojing
    Wang, Jing
    Yang, Wenzhuo
    Wang, Hongyu
    Li, Zijian
    Zhang, Xiangheng
    Chen, Zhenghe
    MEDICAL ONCOLOGY, 2021, 38 (08)
  • [37] Computational study on novel natural inhibitors targeting BCL2
    Xiaye Lv
    Yuting Jiang
    Xinhui Wang
    HaoQun Xie
    Gaojing Dou
    Jing Wang
    Wenzhuo Yang
    Hongyu Wang
    Zijian Li
    Xiangheng Zhang
    Zhenghe Chen
    Medical Oncology, 2021, 38
  • [38] Screening for c-Myc inhibitors from natural resources
    Liu Ziyu
    Ishikawa, Kosuke
    Semba, Kentaro
    Osada, Hiroyuki
    Watanabe, Nobumoto
    CANCER SCIENCE, 2022, 113 : 979 - 979
  • [39] Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future
    Kim, YJ
    Uyama, H
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (15) : 1707 - 1723
  • [40] Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future
    Y.-J. Kim
    H. Uyama
    Cellular and Molecular Life Sciences CMLS, 2005, 62 : 1707 - 1723